Sustaining a bioartificial liver under hypothermic conditions.
Tissue Eng
; 11(3-4): 427-37, 2005.
Article
en En
| MEDLINE
| ID: mdl-15869421
Bioartificial liver (BAL) devices employing xenogeneic hepatocytes are being developed as a temporary support of liver failure. For clinical applications, transporting such a device from the manufacturing site to the hospital is necessary. We investigated the effect of hypothermic treatment on the performance of the collagen-entrapment BAL device developed at the University of Minnesota. A number of chemical protectants were examined for their effectiveness in minimizing damage to hepatocytes. Preincubation with protectant (tauroursodeoxycholic acid, TUDCA) before hypothermic treatment improved posttreatment BAL performance. Oxygen consumption and albumin and urea synthesis all resumed at levels comparable to pretreatment levels. The method described will facilitate the application of BAL in the treatment of liver failure.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Preservación de Órganos
/
Criopreservación
/
Técnicas de Cultivo de Célula
/
Hígado Artificial
/
Hepatocitos
/
Ingeniería de Tejidos
/
Hipotermia Inducida
Tipo de estudio:
Evaluation_studies
Límite:
Animals
Idioma:
En
Revista:
Tissue Eng
Asunto de la revista:
BIOTECNOLOGIA
/
HISTOLOGIA
Año:
2005
Tipo del documento:
Article
País de afiliación:
Estados Unidos
Pais de publicación:
Estados Unidos